MedTrace Logo

Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk Patients

NCT01022905 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1141

Last updated 2010-03-01

No results posted yet for this study

Summary

The objective of this study is to assess vaccine responses to novel adjuvanted influenza A(H1N1) vaccines in patients at high risks of influenza A(H1N1) complications.

Conditions

  • HIV Infection
  • Rheumatic Disease
  • Cancer
  • Transplant
  • Pediatrics

Interventions

BIOLOGICAL

Adjuvanted influenza A(H1N1) vaccines

Immunization (1-2 doses)

Sponsors & Collaborators

  • University Hospital, Geneva

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2010-02-28
Completion
2010-02-28

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01022905 on ClinicalTrials.gov